Best in 7 days Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3 US$ 26.74 Sold : Login>>
Novo Nordisk's next-gen obesity drug CagriSema trial results disappoint investors US$ 24.50 Min. order: 1 piece ★★★★★ 4.9 (267 reviews) Sold : Login>>
Novo's Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial US$ 21.01 Min. order: 1 piece ★★★★★ 4.6 (139 reviews) Sold : Login>>
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 22.52 Min. order: 1 piece ★★★★★ 4.2 (272 reviews) Sold : Login>>
Peptide Tools & Guides – Atlas Nutrition US$ 21.65 Min. order: 1 piece ★★★★★ 4.3 (175 reviews) Sold : Login>>
Novo Nordisk presents new Phase III data for next-gen amylin cagrilintide US$ 24.64 Min. order: 1 piece ★★★★★ 4.7 (145 reviews) Sold : Login>>